Innokas Medical’s Scandinavian growth strategy brings first customer from Denmark
Danish company RSP Systems has selected Innokas Medical to develop a prototype for a non-invasive glucose monitoring device.
This partnership completes a hat-trick of the Scandinavian countries and is a significant step in developing Innokas’ position on the Nordic market. Innokas Medical first contacted RSP Systems in October 2015.
‘’By the time we met again six months later, RSP had good results from their research and were already thinking about developing and productizing the next version of the device,” Antti Virtanen, Account Manager at Innokas Medical says.
“We chose Innokas Medical because of its long-term experience in the design and manufacturing of medical devices. We have found that there is a good understanding of RSP’s needs and willingness to be flexible when needed,” Stefan O. Banke, co-founder and CTO of RSP Systems adds.
The development of RSP’s GlucoBeam® product offers exciting possibilities for the future as it enables painless monitoring of diabetes patients’ glucose levels by measuring the tissue fluid surrounding the cells of the body. According to Virtanen, about two hundred FDA applications for non-invasive glucose measurement have been rejected over the years, so the success of the GlucoBeam® would represent a major breakthrough.
Innokas Medical is a medical technology company whose service offering covers the entire path of bringing new medical products to the market, including product development, contract manufacturing, and quality and regulatory services.